RUNX1 and leukemia: In this pursuit, we focussed on human AML driven by MLL-rearrangements, RUNX1-ETO translocations and those characterized by complex karyotypic lesions and assessed if and how those different leukaemia contexts would display a characteristic phenotypic modulation in response to MYB suppression.